InMed Pharmaceuticals Inc (INM)

[lesgetrich]

The brokerages that handled the $5.7 million public offering obviously thought that the company was worth roughly $.33 USD ($.45 CAD) and would at least reach $.48 USD ($.65 CAD) for the warrants.

This should be regarded as a long term hold for a year or two+, not a quick flip trade for profit. The pps could dip down on low volume or lack of updates but I doubt it would ever get much below $.20 USD again. Right now, I think we're heading back above $.33 USD and on the way back up to $.44 USD ($.59 CAD) where we were at before the offering price was announced. JMO